Adaptimmune Therapeutics Plc Est. EPS Q / Q
Mi az Adaptimmune Therapeutics Plc Est. EPS Q / Q?
A Est. EPS Q / Q az Adaptimmune Therapeutics Plc - 0.00%
Mi a Est. EPS Q / Q meghatározása?
A várható EPS negyedévenkénti növekedési üteme évről évre meghaladja a vállalat EPS-jének becsült növekedését a következő negyedévben az előző negyedévhez képest.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q a Health Care szektor a NASDAQ-on cégekben a Adaptimmune Therapeutics Plc -hoz képest
Mit csinál Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
est. eps q / q -hoz hasonló cégek Adaptimmune Therapeutics Plc
- Prestige Estates Projects nak Est. EPS Q / Q -0.40% van
- Cigna nak Est. EPS Q / Q -0.35% van
- Can Fin Homes nak Est. EPS Q / Q -0.33% van
- Teleflex nak Est. EPS Q / Q -0.28% van
- Ipca Laboratories nak Est. EPS Q / Q -0.24% van
- Zebra Technologies nak Est. EPS Q / Q -0.22% van
- Adaptimmune Therapeutics Plc nak Est. EPS Q / Q 0.00% van
- Teledyne Technologies Inc nak Est. EPS Q / Q 0.22% van
- Universal Health Services nak Est. EPS Q / Q 0.34% van
- Idexx Laboratories nak Est. EPS Q / Q 0.49% van
- Discover Services nak Est. EPS Q / Q 0.55% van
- United Parcel Service nak Est. EPS Q / Q 0.56% van
- TMX nak Est. EPS Q / Q 0.56% van